|
|
|
|
| LEADER |
01745nam a22004337a 4500 |
| 001 |
MUB01001024808 |
| 003 |
CZ BrMU |
| 005 |
20200131062809.0 |
| 008 |
150223s2012 xxu||||| |||||||||||eng d |
| STA |
|
|
|a POSLANO DO SKCR
|b 2021-03-22
|
| 020 |
|
|
|a 978-1-62100-596-4
|
| 040 |
|
|
|a BOD002
|b cze
|
| 072 |
|
7 |
|a 615
|x Farmacie. Farmakologie
|2 Konspekt
|9 14
|
| 080 |
|
|
|a 615.277.3
|2 MRF
|
| 245 |
0 |
0 |
|a Methotrexate :
|b pharmacology, clinical uses and adverse effects /
|c ed. Valentina S. Castillo and Laura A. Moyano
|
| 260 |
|
|
|a New York :
|b Nova Science,
|c c2012
|
| 300 |
|
|
|a xii, 266 s. :
|b il.
|
| 490 |
1 |
|
|a Pharmacology-research, safety testing and regulation
|
| 650 |
0 |
2 |
|a Methotrexate
|
| 650 |
0 |
2 |
|a Neoplasms
|
| 650 |
0 |
7 |
|a methotrexát
|x diagnostické užití
|2 czmesh
|
| 650 |
0 |
7 |
|a methotrexát
|x farmakologie
|2 czmesh
|
| 650 |
0 |
7 |
|a methotrexát
|x škodlivé účinky
|2 czmesh
|
| 650 |
0 |
7 |
|a nádory
|x terapie
|2 czmesh
|
| 700 |
1 |
|
|a Castillo, Valentina S.
|7 mub20201064594
|4 edt
|
| 700 |
1 |
|
|a Moyano, Laura A.
|4 edt
|
| 830 |
|
0 |
|a Pharmacology-research, safety testing and regulation
|
| CAT |
|
|
|a PELZOVA
|b 02
|c 20150223
|l MUB01
|h 0812
|
| CAT |
|
|
|a CECHOVA
|b 02
|c 20150223
|l MUB01
|h 1145
|
| CAT |
|
|
|c 20150404
|l MUB01
|h 0941
|
| CAT |
|
|
|a BATCH
|b 00
|c 20151226
|l MUB01
|h 0534
|
| CAT |
|
|
|a VARTECKA
|b 02
|c 20200131
|l MUB01
|h 0628
|
| CAT |
|
|
|c 20210322
|l MUB01
|h 0938
|
| CAT |
|
|
|c 20210614
|l MUB01
|h 1013
|
| CAT |
|
|
|c 20210614
|l MUB01
|h 2000
|
| LOW |
|
|
|a POSLANO DO SKCR
|b 2021-03-22
|
| 994 |
- |
1 |
|l MUB01
|l MUB01
|m BOOK
|1 KUK
|a Knihovna univ. kampusu
|2 KDO
|b Klinika dětské onkologie
|6 3147063703
|5 3147063703
|8 20150223
|f 78
|f Mimo UK
|g 2015-438
|r 20150223
|s grant
|
| AVA |
|
|
|a MED50
|b KUK
|c Klinika dětské onkologie
|e available
|t K dispozici
|f 1
|g 0
|h N
|i 0
|j KDO
|
